Home › Peripheral Arterial Disease › Michigan › Detroit
Peripheral Arterial Disease clinical trials in Detroit, MI
6 studies for Peripheral Arterial Disease are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Improving Mobility After Revascularization in Peripheral Artery Disease
RecruitingPhase 3
- Henry Ford Health, Detroit
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RecruitingPhase 3
- Henry Ford Health System, Detroit
Vascular Trial Associated Registry Pilot
RecruitingPhase 4
- Henry Ford Hospital, Detroit
The THOR IDE Study
Recruiting
- Henry Ford St John Hospital, Detroit
- Henry Ford Hospital, Detroit
Serranator POINT FORCE Registry
RecruitingObservational study
- Henry Ford Health, Detroit
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
RecruitingObservational study
- Detroit Medical Center, Detroit
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Boston, MA10 studies
- Dallas, TX9 studies
- Cleveland, OH9 studies
- Chicago, IL9 studies
- Houston, TX8 studies
- Omaha, NE7 studies
- Gainesville, FL7 studies
- Nashville, TN6 studies
- Miami, FL6 studies
- Minneapolis, MN6 studies
- Aurora, CO6 studies
- New York City, NY6 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.